The report "Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) - Global Forecasts to 2023", The cell harvesting market is expected to reach USD 324.5 Million by 2023 from USD 213.8 Million in 2018, at a CAGR of 8.7% from 2018 to 2023. Rising investments in regenerative medicine and cell-based research, growth of the biotechnology and biopharmaceutical industry, and increasing incidence of chronic and infectious diseases are the major factors that are driving the growth of this market.

Browse 67 market data Tables and 27 Figures spread through 101 Pages and in-depth TOC on "Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) - Global Forecasts to 2023"

https://www.marketsandmarkets.com/Market-Reports/cell-harvesting-market-209513544.html

Cell harvesting is the process of harvesting cells from the culture media during upstream and downstream bioprocessing. Cell harvesters are used extensively for the cell harvesting process and are compatible with a wide range of assays. The global market for cell harvesting is expected to reach USD 324.5 Million by 2023 from USD 213.8 Million in 2018, at a CAGR of 8.7%. Rising investments in regenerative medicine and cell-based research, growth of the biopharmaceutical and biotechnology industry, and increasing incidence of chronic and infectious diseases are the major driving factors for this market.
The cell harvesting market is segmented on the basis of type, application, and end user. The market based on application is segmented into research institutes, biotechnology & biopharmaceutical companies, and other end users. The biotechnology & biopharmaceutical companies segment is expected to account for the largest share of the market in 2018. The growth in this segment is primarily attributed to high prevalence of chronic diseases worldwide and the increasing R&D activities to develop new products across the globe.
Based on type, the market for cell harvesting is segmented into manual and automated cell harvesters. The manual cell harvesters segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to their ease of use and low price as compared to automated harvesters.
The growing use of single-use bioprocessing containers is expected to hinder the growth of this market in the coming years.
PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan) are the major players in this market.